Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: Involvement of μ and κ opiate receptor subtypes

Journal of Neuroendocrinology

Volumn 8, Issue 10, 1996, Pages 771-776

  Callahan, Phyllis ^a   Baumann, Michael H ^b   Rabii, Jamshid ^c,d  

^a MIAMI UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

Author keywords

Lactation; Nor binaltorphimine; funaltrexamine

Indexed keywords

BETA FUNALTREXAMINE; DOPA; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NORBINALTORPHIMINE; OPIATE ANTAGONIST; PROLACTIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; LACTATION; MEDIAL PREOPTIC AREA; MEDIAN EMINENCE; NERVE CELL INHIBITION; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RAT; SEROTONINERGIC SYSTEM; SUCKLING; TUBEROHYPOPHYSEAL TRACT;

EID: 0029740657     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.05207.x     Document Type: Article

References (53)

1. Neill JD, Nagy GM. Prolactin secretion and its control. In: Knobil E, Neill JD, eds. The Physiology of Reproduction, 2nd edn. New York: Raven Press, 1994: 1833-1860.
2. Ben-Jonathan N. Dopamine: A prolactin inhibiting hormone. Endocrine Rev. 1985; 6: 564-589.
3. Lamberts SWJ, MacLeod RM. Regulation of prolactin secretion at the level of the lactotroph. Physiol. Rev. 1990; 70: 279-318.
4. Kordon C, Drouva SV, Martinez dela Escalera G. et al. Role of classic and peptide neuromediators in the neuroendocrine regulation of luteinizing hormone and prolactin. In: E Knobil, Neill JD, eds. The Physiology of Reproduction, 2nd edn. New York: Raven Press, 1994: 1621-1681.
5. Kehoe L, Parman R, Janik J, Callahan P. Opiate receptor subtype involvement in the stimulation of prolactin release by β-endorphin in female rats. Neuroendocrinology 1993; 57: 875-883.
6. 1 opioid receptor subtype in the regulation of prolactin and growth hormone secretion by beta-endorphin in female rats: Studies with naloxonazine. J Neuroendocrinology 1992; 4: 701-708.
7. Eppler CM, Hulmes JD, Wang JB, et al. Purification and partial amino acid sequence of a μ opiod receptor from rat brain. J Biol Chem 1993; 268: 26447-26451.
8. Minami M, Onogi T, Toya T et al. Molecular cloning and in situ hybridization histochemistry for rat μ opioid receptor. Neurosci Res 1994; 18: 315-322.
9. Thompson RC, Mansour A, Akil H et al., Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 1993; 11: 903-913.
10. Wang JB, Imai Y, Eppler CM et al. μ opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci 1993; 90: 10230-10234.
11. Zastawny RL, George SR, Nguyen T et al. Cloning, characterization and distribution of a μ opioid receptor in rat brain. J Neurochem 1994; 62: 2099-2105.
12. Evans CJ, Keith DE, Morrison H et al. Cloning of a delta opioid receptor by functional expression. Sci 1992; 258: 1952-1955.
13. Kieffer BL, Befort K, Gaveriaux-Ruff C et al. The δe-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Science 1992; 89: 12048-12052.
14. Chen Y, Mestek A, Liu J et al. Molecular cloning a rat κ opioid receptor reveals sequence similarities to the μ and δ opioid receptors. Biochem J 1993; 295: 625-628.
15. Li S, Zhu J. Chen C et al. Molecular cloning and expression of a rat κ opioid receptor. Biochem J. 1993; 295: 629-633.
16. Meng F, Xie G, Thompson RC et al. Cloning and pharmacological characterization of a rat κ opioid receptor. Proc Natl Acad Sci 1993; 90: 9954-9958.
17. Minami M, Toya T, Katao Y et al. Cloning and expression of a cDNA for the rat κ opioid receptor. FEBS 1993; 329: 291-295.
18. Nishi M, Takeshima H, Fukuda K et al. cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for κ subtype-selective ligands. FEBS 1993; 330: 77-80.
19. Xie G, Meng F, Mansour A et al. Primary structure and functional expression of a guinea pig κ opioid (dynorphin) receptor. Proc Natl Acad Sci 1994; 91: 3779-3783.
20. Manzanares J, Wagner EJ, LaVigne SD el al. Sexual differences in kappa opioid mediated regulation of tuberoinfundibular dopaminergic neurons. Neuroendocrinology 1992; 55: 301-307.
21. Mercanthaler I. Induction of enkephalin in tuberoinfundibular dopaminergic neurons during lactation. Endocrinology 1993; 133: 2645-2651.
22. Demarest KT, McKay DW, Reigle GD et al Biochemical indices of tuberoinfundibular dopaminergic neuronal activity during lactation: A lack of response to prolactin. Neuroendocrinology 1983; 36: 130-137.
23. Selmanoff M, Wise PM. Decreased dopamine turnover in the median eminence in response to suckling in the lactating rat. Brain Res. 1981; 212: 101-115.
24. Moore KE. Hypothalamic dopaminergic neuronal systems. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: 1987: 127-139.
25. Baumann M, Rabii J. Inhibition of suckling-induced prolactin release by μand κ-opioid antagonists. Bruin Res. 1991; 567: 224-230.
26. Baumann M, Rabii J. Mu selective opioid peptides stimulate prolactin release in lactating rats. J Neuroendocrinol 1990; 2: 271-276.
27. Wang HJ, Hoffman GE, Smith MS. Suppressed tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic system during lactation. Endocrinology 1994; 133: 1657-1663.
28. Arbogast LA, Voogt J. The responsiveness of tuberoinfundibular dopaminergic neurons to prolactin feedback is diminished between early lactation and midlactation in the rat. Endocrinology 1996; 137: 47-54.
29. Moore KE, Lookingland KJ. Dopaminergic neuronal systems in the hypothalamus. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: the fifth generation of progress. New York: Raven Press; 1995: 245-256.
30. Manzanares J, Lookingland KJ. Moore KE. Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J Plarm Exp Ther 1991; 256: 500-505.
31. Parisi MN, Vitale ML, Villar MJ. et al. Serotonergic terminals in the anterior hypothalamic nucleus involved in the prolactin release during suckling. Endocrinology 1987; 120: 2404-2412.
32. Johnston CA, Demarest KT, Moore KE 5-Hydroxytryptamine synthesis and metabolism in discrete nuclei of the rat brain during surges of prolactin associated with restraint stress or suckling. Neuroendocrinology 1984; 38: 117-122.
33. Goodman RR, Adler BA, Pasternak GW. Regional distribution of opiate receptors. In: Pasternak GW, ed. The Opiate Receptors. Clifton. Humana Press, 1988: 197-230.
34. 2 opioid receptors in rat and guinea pig brain. Brain Res. 1991; 562: 57-65.
35. Mansour A, Fox CA, Akil H. et al. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implication. Trends Neural Sci 1995; 19: 22-29.
36. George SR, Zastawny RL, Briones-Urbina R et al. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Comm 1994; 205: 1438-1444.
37. B and μ-opioid receptor agonists: Evidence for convergence at a ligand-gated potassium conductance. Neuroendocrinology 1991; 54: 537-544.
38. Horvath TL, Naftolin F, Leranth C. β-endorphin innervation of dopamine neurons in the rat hypothalamus: A light and electron microscopic double immunostaining study. Endocrinol 1992; 131: 1547-1555.
39. Millan MJ, Cavonkowski A, Lipkowski A et al. Kappa-opioid receptor mediated antinociception in the rat. II Supraspinal in addition to spinal sites of action. J Pharmacol Exp Ther 1989; 251: 342-350.
40. Pfeiffer DG, Pfeiffer A, Almeida OFX el al. Opiate suppression of LH secretion involves central receptors different from mediating opiate effects on prolactin secretion. J Endocrinol 1987; 114: 469-476.
41. Portoghese PS, Lipkowski AW, Takemori AE. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists. Life Sci 1987; 4: 1287-1292.
42. Portoghese PS, Sultana M, Takemori AE. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmcol. 1988; 146: 185-191.
43. deGreef WJ, Visser TJ. Evidence for the involvement of hypothalamic dopamine and TRH in suckling-induced release of prolactin. J Endocrinol 1981; 91: 213-216.
44. deGreef WJ, Voogt JL, Visser TJ el al. Control of prolactin release induced by suckling. Endocrinology 1987; 121: 316.
45. Grosvernor CE, Mena F, Whitworth NS. Evidence that the dopaminergic prolactin-inhibiting factor mechanism regulates only the depletion-transformation phase and not the release phase of prolactin secretion during suckling in the rat. Endocrinology 1980; 106: 481-486.
46. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press, New York: 1982.
47. Takemori AE, Larson DL, Portoghese PS. The irreversible antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 1981; 70: 445-451.
48. Ward SF, Portoghese PS, Takemori AE. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. J Pharmacol Exp Ther 1982; 220: 494-498.
49. Takemori AE, By H, Naeseth JS et al. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Expt Ther 1988; 246: 255-258.
50. Janik J, Klosterman S, Parman R et al. Multiple opiate receptor subtypes are involved in the stimulation of growth hormone release by beta-endorphin in female rats. Neuroendocrinology 1994; 60: 69-75.
51. Palkovits M, Brownstein MJ. Maps and guide 10 microdissection of the rat brain. New York: Elsevier 1988: 207.
52. Baumann MH, Raley TJ, Partilla JS et al. Biosynthesis of dopamine and serotonin in the rat brain after repeated cocaine injections: A microdissection mapping study. Synapse 1993; 14: 40-50.
53. Bradford MM A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principles of dye binding. Anal Biochem. 1976; 72: 248-254.